UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000010844
Receipt No. R000012460
Scientific Title Phase II trial with eribulin and trastuzumab for advanced/recurrent HER2-positive breast cancer
Date of disclosure of the study information 2013/06/15
Last modified on 2013/05/30 17:19:51

No. Disposal Last modified on Item of update
1 Insert 2013/05/31 10:09:54


Contact us.